APO Research
Talk to an analyst

APO RESEARCH · REPORT

Age Related Macular Degeneration Drug

Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.

Selected research

Industry Growth & Trends

Global Age Related Macular Degeneration Drug Industry Growth and Trends Forecast to 2032

22 December 202596 pages

Choose your research edition.

Industry ResearchAge Related Macular Degeneration Drug Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Age Related Macular Degeneration Drug Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Age Related Macular Degeneration Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Age Related Macular Degeneration Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Age Related Macular Degeneration Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.

North America is the largest Age Related Macular Degeneration Drug market with about 65% market share. Europe is follower, accounting for about 29% market share.

The key players are Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma etc. Top 3 companies occupied about 79% market share.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Age Related Macular Degeneration Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Age Related Macular Degeneration Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Age Related Macular Degeneration Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Age Related Macular Degeneration Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Age Related Macular Degeneration Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Age Related Macular Degeneration Drug Market by Company

Regeneron Pharmaceuticals

Bayer HealthCare

Novartis

Roche

Kanghong Pharma

Age Related Macular Degeneration Drug Segment by Type

Lucentis

Eylea

Avastin

Others

Age Related Macular Degeneration Drug Segment by Application

Hospitals

Clinics

Others

Age Related Macular Degeneration Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Age Related Macular Degeneration Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Age Related Macular Degeneration Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Age Related Macular Degeneration Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Age Related Macular Degeneration Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Age Related Macular Degeneration Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Lucentis Table 2. Major Company of Eylea Table 3. Major Company of Avastin Table 4. Major Company of Others Table 5. Global Age Related Macular Degeneration Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Age Related Macular Degeneration Drug Sales by Type (2021-2026) & (K Units) Table 7. Global Age Related Macular Degeneration Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Age Related Macular Degeneration Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Age Related Macular Degeneration Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Age Related Macular Degeneration Drug Price by Type (2021-2026) & (USD/Unit) Table 11. Global Age Related Macular Degeneration Drug Sales by Type (2027-2032) & (K Units) Table 12. Global Age Related Macular Degeneration Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Age Related Macular Degeneration Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Age Related Macular Degeneration Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Age Related Macular Degeneration Drug Price by Type (2027-2032) & (USD/Unit) Table 16. North America Age Related Macular Degeneration Drug Sales by Type (2021-2026) & (K Units) Table 17. North America Age Related Macular Degeneration Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Age Related Macular Degeneration Drug Sales by Type (2021-2026) & (K Units) Table 19. Europe Age Related Macular Degeneration Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Age Related Macular Degeneration Drug Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Age Related Macular Degeneration Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Age Related Macular Degeneration Drug Sales by Type (2021-2026) & (K Units) Table 23. Latin America Age Related Macular Degeneration Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Age Related Macular Degeneration Drug Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Age Related Macular Degeneration Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Age Related Macular Degeneration Drug Industry Trends Table 27. Age Related Macular Degeneration Drug Industry Drivers Table 28. Age Related Macular Degeneration Drug Industry Opportunities and Challenges Table 29. Age Related Macular Degeneration Drug Industry Restraints Table 30. Global Age Related Macular Degeneration Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Age Related Macular Degeneration Drug Revenue Market Share by Company (2021-2026) Table 32. Global Age Related Macular Degeneration Drug Sales by Company (2021-2026) & (K Units) Table 33. Global Age Related Macular Degeneration Drug Sales Share by Company (2021-2026) Table 34. Global Age Related Macular Degeneration Drug Market Price by Company (2021-2026) & (USD/Unit) Table 35. Global Age Related Macular Degeneration Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Age Related Macular Degeneration Drug Major Company Production Sites and Headquarters Table 37. Global Age Related Macular Degeneration Drug Company, Product Type & Application Table 38. Global Age Related Macular Degeneration Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Age Related Macular Degeneration Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Age Related Macular Degeneration Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Age Related Macular Degeneration Drug Sales by Region (2021-2026) & (K Units) Table 43. Global Age Related Macular Degeneration Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Age Related Macular Degeneration Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Age Related Macular Degeneration Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Age Related Macular Degeneration Drug Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 47. Global Age Related Macular Degeneration Drug Sales by Region (2027-2032) & (K Units) Table 48. Global Age Related Macular Degeneration Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Age Related Macular Degeneration Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Age Related Macular Degeneration Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Age Related Macular Degeneration Drug Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 52. Global Age Related Macular Degeneration Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Age Related Macular Degeneration Drug Sales by Application (2021-2026) & (K Units) Table 54. Global Age Related Macular Degeneration Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Age Related Macular Degeneration Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Age Related Macular Degeneration Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Age Related Macular Degeneration Drug Price by Application (2021-2026) & (USD/Unit) Table 58. Global Age Related Macular Degeneration Drug Sales by Application (2027-2032) & (K Units) Table 59. Global Age Related Macular Degeneration Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Age Related Macular Degeneration Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Age Related Macular Degeneration Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Age Related Macular Degeneration Drug Price by Application (2027-2032) & (USD/Unit) Table 63. North America Age Related Macular Degeneration Drug Sales by Application (2021-2026) & (K Units) Table 64. North America Age Related Macular Degeneration Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Age Related Macular Degeneration Drug Sales by Application (2021-2026) & (K Units) Table 66. Europe Age Related Macular Degeneration Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Age Related Macular Degeneration Drug Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Age Related Macular Degeneration Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Age Related Macular Degeneration Drug Sales by Application (2021-2026) & (K Units) Table 70. Latin America Age Related Macular Degeneration Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Age Related Macular Degeneration Drug Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Age Related Macular Degeneration Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Regeneron Pharmaceuticals Company Information Table 74. Regeneron Pharmaceuticals Business Overview Table 75. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product Portfolio Table 77. Regeneron Pharmaceuticals Recent Development Table 78. Bayer HealthCare Company Information Table 79. Bayer HealthCare Business Overview Table 80. Bayer HealthCare Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Bayer HealthCare Age Related Macular Degeneration Drug Product Portfolio Table 82. Bayer HealthCare Recent Development Table 83. Novartis Company Information Table 84. Novartis Business Overview Table 85. Novartis Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Novartis Age Related Macular Degeneration Drug Product Portfolio Table 87. Novartis Recent Development Table 88. Roche Company Information Table 89. Roche Business Overview Table 90. Roche Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Roche Age Related Macular Degeneration Drug Product Portfolio Table 92. Roche Recent Development Table 93. Kanghong Pharma Company Information Table 94. Kanghong Pharma Business Overview Table 95. Kanghong Pharma Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Kanghong Pharma Age Related Macular Degeneration Drug Product Portfolio Table 97. Kanghong Pharma Recent Development Table 98. North America Age Related Macular Degeneration Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 99. North America Age Related Macular Degeneration Drug Sales by Country (2021-2026) & (K Units) Table 100. North America Age Related Macular Degeneration Drug Sales Market Share by Country (2021-2026) Table 101. North America Age Related Macular Degeneration Drug Sales Forecast by Country (2027-2032) & (K Units) Table 102. North America Age Related Macular Degeneration Drug Sales Market Share Forecast by Country (2027-2032) Table 103. North America Age Related Macular Degeneration Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Age Related Macular Degeneration Drug Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Age Related Macular Degeneration Drug Market Share by Country (2021-2026) Table 106. North America Age Related Macular Degeneration Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Age Related Macular Degeneration Drug Market Share Forecast by Country (2027-2032) Table 108. Europe Age Related Macular Degeneration Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 109. Europe Age Related Macular Degeneration Drug Sales by Country (2021-2026) & (K Units) Table 110. Europe Age Related Macular Degeneration Drug Sales Market Share by Country (2021-2026) Table 111. Europe Age Related Macular Degeneration Drug Sales Forecast by Country (2027-2032) & (K Units) Table 112. Europe Age Related Macular Degeneration Drug Sales Market Share Forecast by Country (2027-2032) Table 113. Europe Age Related Macular Degeneration Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Age Related Macular Degeneration Drug Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Age Related Macular Degeneration Drug Market Share by Country (2021-2026) Table 116. Europe Age Related Macular Degeneration Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Age Related Macular Degeneration Drug Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Age Related Macular Degeneration Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Age Related Macular Degeneration Drug Sales by Country (2021-2026) & (K Units) Table 120. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share by Country (2021-2026) Table 121. Asia-Pacific Age Related Macular Degeneration Drug Sales Forecast by Country (2027-2032) & (K Units) Table 122. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Age Related Macular Degeneration Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Age Related Macular Degeneration Drug Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Age Related Macular Degeneration Drug Market Share by Country (2021-2026) Table 126. Asia-Pacific Age Related Macular Degeneration Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Age Related Macular Degeneration Drug Market Share Forecast by Country (2027-2032) Table 128. Latin America Age Related Macular Degeneration Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Latin America Age Related Macular Degeneration Drug Sales by Country (2021-2026) & (K Units) Table 130. Latin America Age Related Macular Degeneration Drug Sales Market Share by Country (2021-2026) Table 131. Latin America Age Related Macular Degeneration Drug Sales Forecast by Country (2027-2032) & (K Units) Table 132. Latin America Age Related Macular Degeneration Drug Sales Market Share Forecast by Country (2027-2032) Table 133. Latin America Age Related Macular Degeneration Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Age Related Macular Degeneration Drug Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Age Related Macular Degeneration Drug Market Share by Country (2021-2026) Table 136. Latin America Age Related Macular Degeneration Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Age Related Macular Degeneration Drug Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa Age Related Macular Degeneration Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa Age Related Macular Degeneration Drug Sales by Country (2021-2026) & (K Units) Table 140. Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share by Country (2021-2026) Table 141. Middle East and Africa Age Related Macular Degeneration Drug Sales Forecast by Country (2027-2032) & (K Units) Table 142. Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Age Related Macular Degeneration Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Age Related Macular Degeneration Drug Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East and Africa Age Related Macular Degeneration Drug Market Share by Country (2021-2026) Table 146. Middle East and Africa Age Related Macular Degeneration Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Age Related Macular Degeneration Drug Market Share Forecast by Country (2027-2032) Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Age Related Macular Degeneration Drug Distributors List Table 151. Age Related Macular Degeneration Drug Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Age Related Macular Degeneration Drug Image Figure 2. Global Age Related Macular Degeneration Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Age Related Macular Degeneration Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Age Related Macular Degeneration Drug Sales (2021-2032) & (K Units) Figure 5. Lucentis Image Figure 6. Global Lucentis Sales YoY Growth (2021-2032) & (K Units) Figure 7. Eylea Image Figure 8. Global Eylea Sales YoY Growth (2021-2032) & (K Units) Figure 9. Avastin Image Figure 10. Global Avastin Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Age Related Macular Degeneration Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Age Related Macular Degeneration Drug Market Share by Type 2025 VS 2032 Figure 15. North America Age Related Macular Degeneration Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Age Related Macular Degeneration Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Age Related Macular Degeneration Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Age Related Macular Degeneration Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Age Related Macular Degeneration Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Age Related Macular Degeneration Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Age Related Macular Degeneration Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospitals Image Figure 28. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 29. Clinics Image Figure 30. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Age Related Macular Degeneration Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Age Related Macular Degeneration Drug Market Share by Application 2025 VS 2032 Figure 35. North America Age Related Macular Degeneration Drug Sales Market Share in Volume by Application in 2025 Figure 36. North America Age Related Macular Degeneration Drug Sales Market Share in Value by Application in 2025 Figure 37. Europe Age Related Macular Degeneration Drug Sales Market Share in Volume by Application in 2025 Figure 38. Europe Age Related Macular Degeneration Drug Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share in Value by Application in 2025 Figure 41. Latin America Age Related Macular Degeneration Drug Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Age Related Macular Degeneration Drug Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share in Value by Application in 2025 Figure 45. North America Age Related Macular Degeneration Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Age Related Macular Degeneration Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Age Related Macular Degeneration Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Age Related Macular Degeneration Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Age Related Macular Degeneration Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Age Related Macular Degeneration Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Age Related Macular Degeneration Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Age Related Macular Degeneration Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Age Related Macular Degeneration Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Age Related Macular Degeneration Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Age Related Macular Degeneration Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Age Related Macular Degeneration Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Age Related Macular Degeneration Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Age Related Macular Degeneration Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Age Related Macular Degeneration Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Age Related Macular Degeneration Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Age Related Macular Degeneration Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Age Related Macular Degeneration Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Age Related Macular Degeneration Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Age Related Macular Degeneration Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Age Related Macular Degeneration Drug Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Age Related Macular Degeneration Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Lucentis
  • Eylea
  • Avastin
  • Others
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Regeneron Pharmaceuticals
  • Bayer HealthCare
  • Novartis
  • Roche
  • Kanghong Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Age Related Macular Degeneration Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Age Related Macular Degeneration Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Age Related Macular Degeneration Drug Market by Type
  6. 1.3.1 Lucentis
  7. 1.3.2 Eylea
  8. 1.3.3 Avastin
  9. 1.3.4 Others
  10. 1.4 Global Age Related Macular Degeneration Drug Market Size by Type
  11. 1.4.1 Global Age Related Macular Degeneration Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Age Related Macular Degeneration Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Age Related Macular Degeneration Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Age Related Macular Degeneration Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Age Related Macular Degeneration Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Age Related Macular Degeneration Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Age Related Macular Degeneration Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Age Related Macular Degeneration Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Age Related Macular Degeneration Drug Industry Trends
  2. 2.2 Age Related Macular Degeneration Drug Industry Drivers
  3. 2.3 Age Related Macular Degeneration Drug Industry Opportunities and Challenges
  4. 2.4 Age Related Macular Degeneration Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Age Related Macular Degeneration Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Age Related Macular Degeneration Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Age Related Macular Degeneration Drug Price (2021-2026)
  4. 3.4 Global Age Related Macular Degeneration Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Age Related Macular Degeneration Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Age Related Macular Degeneration Drug Company, Product Type & Application
  7. 3.7 Global Age Related Macular Degeneration Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Age Related Macular Degeneration Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Age Related Macular Degeneration Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Age Related Macular Degeneration Drug Tier 1, Tier 2, and Tier 3
4 Age Related Macular Degeneration Drug Regional Status and Outlook
  1. 4.1 Global Age Related Macular Degeneration Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Age Related Macular Degeneration Drug Historic Market Size by Region
  3. 4.2.1 Global Age Related Macular Degeneration Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Age Related Macular Degeneration Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Age Related Macular Degeneration Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Age Related Macular Degeneration Drug Forecasted Market Size by Region
  7. 4.3.1 Global Age Related Macular Degeneration Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Age Related Macular Degeneration Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Age Related Macular Degeneration Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Age Related Macular Degeneration Drug by Application
  1. 5.1 Age Related Macular Degeneration Drug Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Age Related Macular Degeneration Drug Market Size by Application
  6. 5.2.1 Global Age Related Macular Degeneration Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Age Related Macular Degeneration Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Age Related Macular Degeneration Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Age Related Macular Degeneration Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Age Related Macular Degeneration Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Age Related Macular Degeneration Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Age Related Macular Degeneration Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Age Related Macular Degeneration Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Regeneron Pharmaceuticals
  2. 6.1.1 Regeneron Pharmaceuticals Company Information
  3. 6.1.2 Regeneron Pharmaceuticals Business Overview
  4. 6.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product Portfolio
  6. 6.1.5 Regeneron Pharmaceuticals Recent Developments
  7. 6.2 Bayer HealthCare
  8. 6.2.1 Bayer HealthCare Company Information
  9. 6.2.2 Bayer HealthCare Business Overview
  10. 6.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bayer HealthCare Age Related Macular Degeneration Drug Product Portfolio
  12. 6.2.5 Bayer HealthCare Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Age Related Macular Degeneration Drug Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Roche
  20. 6.4.1 Roche Company Information
  21. 6.4.2 Roche Business Overview
  22. 6.4.3 Roche Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Roche Age Related Macular Degeneration Drug Product Portfolio
  24. 6.4.5 Roche Recent Developments
  25. 6.5 Kanghong Pharma
  26. 6.5.1 Kanghong Pharma Company Information
  27. 6.5.2 Kanghong Pharma Business Overview
  28. 6.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Kanghong Pharma Age Related Macular Degeneration Drug Product Portfolio
  30. 6.5.5 Kanghong Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Age Related Macular Degeneration Drug Sales by Country
  2. 7.1.1 North America Age Related Macular Degeneration Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Age Related Macular Degeneration Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Age Related Macular Degeneration Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Age Related Macular Degeneration Drug Market Size by Country
  6. 7.2.1 North America Age Related Macular Degeneration Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Age Related Macular Degeneration Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Age Related Macular Degeneration Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Age Related Macular Degeneration Drug Sales by Country
  2. 8.1.1 Europe Age Related Macular Degeneration Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Age Related Macular Degeneration Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Age Related Macular Degeneration Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Age Related Macular Degeneration Drug Market Size by Country
  6. 8.2.1 Europe Age Related Macular Degeneration Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Age Related Macular Degeneration Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Age Related Macular Degeneration Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Age Related Macular Degeneration Drug Sales by Country
  2. 9.1.1 Asia-Pacific Age Related Macular Degeneration Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Age Related Macular Degeneration Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Age Related Macular Degeneration Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Age Related Macular Degeneration Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Age Related Macular Degeneration Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Age Related Macular Degeneration Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Age Related Macular Degeneration Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Age Related Macular Degeneration Drug Sales by Country
  2. 10.1.1 South America Age Related Macular Degeneration Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Age Related Macular Degeneration Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Age Related Macular Degeneration Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Age Related Macular Degeneration Drug Market Size by Country
  6. 10.2.1 South America Age Related Macular Degeneration Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Age Related Macular Degeneration Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Age Related Macular Degeneration Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Age Related Macular Degeneration Drug Sales by Country
  2. 11.1.1 Middle East and Africa Age Related Macular Degeneration Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Age Related Macular Degeneration Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Age Related Macular Degeneration Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Age Related Macular Degeneration Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Age Related Macular Degeneration Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Age Related Macular Degeneration Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Age Related Macular Degeneration Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Age Related Macular Degeneration Drug Value Chain Analysis
  2. 12.1.1 Age Related Macular Degeneration Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Age Related Macular Degeneration Drug Production Mode & Process
  7. 12.2 Age Related Macular Degeneration Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Age Related Macular Degeneration Drug Distributors
  10. 12.2.3 Age Related Macular Degeneration Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst